Compare · ALGN vs MYO
ALGN vs MYO
Side-by-side comparison of Align Technology Inc. (ALGN) and Myomo Inc. (MYO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and MYO operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $10.49B, about 178.9x MYO ($58.6M).
- ALGN has been more active in the news (5 items in the past 4 weeks vs 2 for MYO).
- ALGN has more recent analyst coverage (25 ratings vs 3 for MYO).
- Company
- Align Technology Inc.
- Myomo Inc.
- Price
- -
- -
- Market cap
- $10.49B
- $58.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- AMEX
- IPO
- 2001
- 2017
- News (4w)
- 5
- 2
- Recent ratings
- 25
- 3
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Myomo Inc.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Latest ALGN
- Align Technology to Speak at Upcoming Financial Conference
- SEC Form 4 filed by Director Blackford Quentin S.
- SEC Form 3 filed by new insider Blackford Quentin S.
- Align Technology Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Quentin Blackford to Join Align Technology Board of Directors
- Align Technology Prevails in China Patent Infringement Action Against Angelalign
- SEC Form SCHEDULE 13G filed by Align Technology Inc.
- SEC Form 10-Q filed by Align Technology Inc.
- Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics
- Align Technology Announces Strategic Initiatives Consistent with Long-term Growth and Shareholder Value Creation Objectives
Latest MYO
- Chief Medical Officer Kovelman Harry sold $19,684 worth of shares (15,488 units at $1.27), decreasing direct ownership by 15% to 90,245 units (SEC Form 4)
- Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Amendment: Chief Medical Officer Kovelman Harry sold $30,329 worth of shares (17,500 units at $1.73), decreasing direct ownership by 14% to 105,733 units (SEC Form 4)
- Chief Medical Officer Kovelman Harry sold $29,896 worth of shares (17,250 units at $1.73), decreasing direct ownership by 14% to 105,983 units (SEC Form 4)
- Chief Medical Officer Kovelman Harry covered exercise/tax liability with 22,457 shares and was granted 55,149 shares, increasing direct ownership by 36% to 123,233 units (SEC Form 4)
- Chief Commercial Officer Mitchell Micah was granted 58,409 shares and covered exercise/tax liability with 21,559 shares, increasing direct ownership by 39% to 130,738 units (SEC Form 4)
- Chief Executive Officer Gudonis Paul R was granted 146,909 shares, increasing direct ownership by 11% to 1,434,679 units (SEC Form 4)
- Chief Financial Officer Henry David A was granted 68,644 shares and covered exercise/tax liability with 25,310 shares, increasing direct ownership by 10% to 470,163 units (SEC Form 4)
- SEC Form S-8 filed by Myomo Inc.
- SEC Form 10-Q filed by Myomo Inc.